Phase I Clinical Trial of Human Anti-PD-L1 Antibody Injection (LDP) in Patients With Advanced Malignant Tumors

Clinical trial NCT03908814 · COMPLETED

Trial details

NCT number: NCT03908814
Sponsor: Dragonboat Biopharmaceutical Company Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Tumors

Start date: 2019-04-27
Primary completion: 2023-04-10
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.